Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10800666 | PMC |
| http://dx.doi.org/10.3389/fnagi.2023.1352988 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Expanding the role of CDK4/6 inhibitors in early breast cancer: insights from the NATALEE trial.
Ann Oncol
February 2025
Université Libre de Bruxelles (ULB), Brussels, Belgium; Department of Medical Oncology, Hôpital Universitaire de Bruxelles (HUB), Institut Jules Bordet, Brussels, Belgium. Electronic address:
"To get to know, to discover, to publish-this is the destiny of a scientist" (Froinçois Arago).
Urologia
January 2025
Department of Medicine and Translational Surgery, Università Cattolica del Sacro Cuore, Rome, Italy.
MLL-AF4 upregulates 5-lipoxygenase expression in t(4;11) leukemia cells via the ALOX5 core promoter.
Front Pharmacol
January 2025
Institute of Pharmaceutical Chemistry, Goethe University, Frankfurt, Germany.
5-Lipoxygenase (5-LO), encoded by the gene , is implicated in several pathologies. As key enzyme in leukotriene biosynthesis, 5-LO plays a central role in inflammatory diseases, but the 5-LO pathway has also been linked to development of certain hematological and solid tumor malignancies. Of note, previous studies have shown that the leukemogenic fusion protein MLL-AF4 strongly increases gene promoter activity.
View Article and Find Full Text PDFBasic and translational endocrinology.
Arch Endocrinol Metab
November 2024
Universidade de São Paulo São PauloSP Brasil Universidade de São Paulo, Fisiologia e Biofísica, São Paulo, SP, Brasil.
Protocol optimization and myocardial blood flow quantification in dynamic myocardial perfusion CT-where do we stand?
Eur Radiol
January 2025
Department of Radiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!